Schizophrenia Research
Volume 120, Issue 1 , Pages 177-183 , July 2010

Perinatal folate-related exposures and risk of psychotic symptoms in the ALSPAC birth cohort

  • B. Glaser

      Affiliations

    • The MRC Centre for Causal Analyses in Translational Epidemiology, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK
    • Department of Social Medicine, University of Bristol, Canynge Hall, 39 Whatley Rd, Bristol BS8 2PS, UK
    • Corresponding Author InformationCorresponding author. The MRC Centre for Causal Analyses in Translational Epidemiology, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK. Tel.: +44 117 33 10101; fax: +44 117 33 10123.
    • ,
  • A.E. Ades

      Affiliations

    • Department of Community Based Medicine, Cotham House, University of Bristol, Cotham Hill, Bristol, BS6 6JL, UK
    • ,
  • S. Lewis

      Affiliations

    • Department of Social Medicine, University of Bristol, Canynge Hall, 39 Whatley Rd, Bristol BS8 2PS, UK
    • ,
  • P. Emmet

      Affiliations

    • Department of Social Medicine, University of Bristol, Canynge Hall, 39 Whatley Rd, Bristol BS8 2PS, UK
    • ,
  • G. Lewis

      Affiliations

    • Department of Community Based Medicine, Cotham House, University of Bristol, Cotham Hill, Bristol, BS6 6JL, UK
    • ,
  • G. Davey Smith

      Affiliations

    • The MRC Centre for Causal Analyses in Translational Epidemiology, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK
    • Department of Social Medicine, University of Bristol, Canynge Hall, 39 Whatley Rd, Bristol BS8 2PS, UK
    • ,
  • S. Zammit

      Affiliations

    • Department of Community Based Medicine, Cotham House, University of Bristol, Cotham Hill, Bristol, BS6 6JL, UK
    • Department of Psychological Medicine, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK

Received 25 August 2009 ,Revised 26 February 2010 ,Accepted 7 March 2010.

References 

  1. Allen NC, Bagade S, McQueen MB, Ioannidis JPA, Kavvoura FK, Khoury MJ, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 2008;40(7):827–834
  2. Bassett S, Avramopoulos D, Fallin D. Evidence for parent of origin effect in late-onset Alzheimer disease. Am. J. Med.Genet. 2002;114(6):679–686
  3. Blom HJ, Shaw GM, den Heijer M, Finnell RH. Neural tube defects and folate: case far from closed. Nat. Rev. Neurosci. 2006;7(9):724–731
  4. Brattström L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation. 1998;98(23):2520–2526
  5. CRAN . The Comprehensive R Archive Network. 2008;Retrieved September 29, 2008, from http://cran.r-project.org/
  6. Dale A, Marsh C. The 1991 Census User's Guide. Office for National Statistics; 1993;
  7. Davey Smith G, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?. Int. J. Epidemiol. 2003;32(1):1–22
  8. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc. Natl. Acad. Sci. U.S.A. 2007;104(32):13056–13061
  9. Eaton W, Romanoski A, Anthony J, Nestadt G. Screening for psychosis in the general population with a self-report interview. J. Nerv. Ment. Dis. 1991;179(11):689–693
  10. Friso S, Choi S, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, et al. A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. U.S.A. 2002;99(8):5606–5611
  11. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard C, Matthews R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 1995;10(1):111–113
  12. Gauderman W, Morrison J. QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies. 2006;Retrieved November 3, 2008, from http://hydra.usc.edu/gxe/
  13. Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am. J. Epidemiol. 2007;165(1):1–13
  14. Golding J, Pembrey M, Jones R. ALSPAC — the Avon Longitudinal Study of Parents and Children. I. Study methodology. Paediatr. Perinat. Epidemiol. 2001;15(1):74–87
  15. Gräff J, Mansuy IM. Epigenetic codes in cognition and behaviour. Behav. Brain. Res. 2008;192(1):70–87
  16. Horwood J, Salvi G, Thomas K, Duffy L, Gunnell D, Hollis C, et al. IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. Br. J. Psychiatry. 2008;193(3):185–191
  17. James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr. 2002;132(8):2361S–2366S
  18. Johns L, Cannon M, Singleton N, Murray R, Farrell M, Brugha T, et al. Prevalence and correlates of self-reported psychotic symptoms in the British population. Br. J. Psychiatry. 2004;185:298–305
  19. Jones RW, Ring S, Tyfield L, Hamvas R, Simmons H, Pembrey M, et al. A new human genetic resource: a DNA bank established as part of the Avon longitudinal study of pregnancy and childhood (ALSPAC). Eur. J. Hum. Genet. 2000;8(9):653–660
  20. Jongbloet P, Verbeek A, denHeijer M, Roeleveld N. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms resulting in suboptimal oocyte maturation: a discussion of folate status, neural tube defects, schizophrenia, and vasculopathy. J. Exp. Clin. Assist. Reprod. 2008;5:5
  21. Kendler K, Gallagher T, Abelson J, Kessler R. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch. Gen. Psychiatry. 1996;53(11):1022–1031
  22. Kleiser C, Mensink GBM, Scheidt-Nave C, Kurth B. HuSKY: a healthy nutrition score based on food intake of children and adolescents in Germany. Br. J. Nutr. 2009;102(4):610–618
  23. Lewis SJ, Zammit Stanley, Gunnell David, Smith George Davey. A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005;135B(1):2–4
  24. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS — a Bayesian modelling framework: concepts, structure, and extensibility. Stat. Comput. 2000;10(4):325–337
  25. McNulty H, Scott J. Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status. Br. J. Nutr. 2008;99(Suppl 3):S48–S54
  26. van Os J, Hanssen M, Bijl R, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Arch. Gen. Psychiatry. 2001;58(7):663–668
  27. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol. Med. 2009;39(2):179–195
  28. Perälä J, Suvisaari J, Saarni S, Kuoppasalmi K, Isometsä E, Pirkola S, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry. 2007;64(1):19–28
  29. Poulton R, Caspi A, Moffitt T, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch. Gen. Psychiatry. 2000;57(11):1053–1058
  30. Ramos MI, Allen LH, Mungas DM, Jagust WJ, Haan MN, Green R, et al. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. Am. J. Clin. Nutr. 2005;82(6):1346–1352
  31. Roffman JL, Gollub RL, Calhoun VD, Wassink TH, Weiss AP, Ho BC, et al. MTHFR 677C –>T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val –>Met. Proc. Natl. Acad. Sci. U.S.A. 2008;105(45):17573–17578
  32. Schreier A, Wolke D, Thomas K, Horwood J, Hollis C, Gunnell D, et al. Prospective study of peer victimization in childhood and psychotic symptoms in a nonclinical population at age 12years. Arch. Gen. Psychiatry. 2009;66(5):527–536
  33. Scott J, Chant D, Andrews G, McGrath J. Psychotic-like experiences in the general community: the correlates of CIDI psychosis screen items in an Australian sample. Psychol. Med. 2006;36(2):231–238
  34. Selhub J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J. Nutr. Health Aging. 2002;6(1):39–42
  35. Selhub J, Morris MS, Jacques PF, Rosenberg IH. Folate–vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency. Am. J. Clin. Nutr. 2009;89(2):702S–706S
  36. Shi J, Gershon ES, Liu C. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr. Res. 2008;104(1–3):96–107
  37. Singh SM, Murphy B, O'Reilly R. Involvement of gene–diet/drug interaction in DNA methylation and its contribution to complex diseases: from cancer to schizophrenia. Clin. Genet. 2003;64(6):451–460
  38. Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 2008;9(6):465–476
  39. Waterland RA, Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annu. Rev. Nutr. 2007;27:363–388
  40. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy–Weinberg equilibrium. Am. J. Hum. Genet. 2005;76(5):887–893
  41. Wiles N, Zammit S, Agre P, Singleton N, Meltzer H, Lewis G. Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. Br. J. Psychiatry. 2006;188:519–526
  42. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, et al. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch. Gen. Psychiatry. 1990;47(6):589–593
  43. Zammit S, Horwood J, Thompson A, Thomas K, Menezes P, Gunnell D, et al. Investigating if psychosis-like symptoms (PLIKS) are associated with family history of schizophrenia or paternal age in the ALSPAC birth cohort. Schizophr. Res. 2008;104(1–3):279–286
  44. Zammit S, Odd D, Horwood J, Thompson A, Thomas K, Menezes P, et al. Investigating whether adverse prenatal and perinatal events are associated with non-clinical psychotic symptoms at age 12years in the ALSPAC birth cohort. Psychol. Med. 2009;39(9):1457–1467
  45. Zammit S, Lewis S, Gunnell D, Smith GD. Schizophrenia and neural tube defects: comparisons from an epidemiological perspective. Schizophr. Bull. 2007;33(4):853–858

☆ Re-prints should be sent to the corresponding author. This research was funded by the Department of Social Medicine, University of Bristol.

PII: S0920-9964(10)01176-X

doi: 10.1016/j.schres.2010.03.006

Schizophrenia Research
Volume 120, Issue 1 , Pages 177-183 , July 2010

Article Tools